INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 97 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $9,477 | +31.5% | 45,025 | -0.0% | 0.00% | – |
Q1 2023 | $7,206 | -73.0% | 45,040 | -6.5% | 0.00% | – |
Q4 2022 | $26,733 | -54.7% | 48,166 | -2.3% | 0.00% | – |
Q3 2022 | $59,000 | -59.0% | 49,312 | -78.5% | 0.00% | – |
Q2 2022 | $144,000 | -48.9% | 229,213 | -7.6% | 0.00% | – |
Q1 2022 | $282,000 | +24.2% | 248,177 | +146.6% | 0.00% | – |
Q4 2021 | $227,000 | -82.0% | 100,649 | -72.7% | 0.00% | – |
Q3 2021 | $1,259,000 | +43.7% | 368,291 | +25.7% | 0.00% | – |
Q2 2021 | $876,000 | +14.8% | 293,026 | +24.1% | 0.00% | – |
Q1 2021 | $763,000 | +1907.9% | 236,031 | +1222.6% | 0.00% | – |
Q4 2020 | $38,000 | -7.3% | 17,846 | -49.4% | 0.00% | – |
Q3 2020 | $41,000 | +355.6% | 35,251 | +268.9% | 0.00% | – |
Q2 2020 | $9,000 | +50.0% | 9,556 | +20.7% | 0.00% | – |
Q1 2020 | $6,000 | -25.0% | 7,916 | +3.1% | 0.00% | – |
Q4 2019 | $8,000 | 0.0% | 7,680 | -2.9% | 0.00% | – |
Q3 2019 | $8,000 | -57.9% | 7,909 | -24.0% | 0.00% | – |
Q2 2019 | $19,000 | -17.4% | 10,401 | -12.5% | 0.00% | – |
Q1 2019 | $23,000 | +475.0% | 11,885 | +318.3% | 0.00% | – |
Q4 2018 | $4,000 | -93.5% | 2,841 | -87.5% | 0.00% | – |
Q3 2018 | $62,000 | +93.8% | 22,745 | +36.1% | 0.00% | – |
Q2 2018 | $32,000 | -15.8% | 16,718 | -7.9% | 0.00% | – |
Q1 2018 | $38,000 | +46.2% | 18,149 | +43.1% | 0.00% | – |
Q4 2017 | $26,000 | -76.8% | 12,684 | -85.0% | 0.00% | – |
Q3 2017 | $112,000 | -32.9% | 84,370 | -20.8% | 0.00% | – |
Q2 2017 | $167,000 | -62.2% | 106,512 | -22.3% | 0.00% | – |
Q1 2017 | $442,000 | -9.8% | 137,010 | -62.4% | 0.00% | – |
Q4 2016 | $490,000 | +716.7% | 364,310 | +858.2% | 0.00% | – |
Q3 2016 | $60,000 | +1.7% | 38,020 | -13.9% | 0.00% | – |
Q2 2016 | $59,000 | -76.3% | 44,173 | -6.4% | 0.00% | – |
Q1 2016 | $249,000 | +11.2% | 47,211 | +65.7% | 0.00% | – |
Q4 2015 | $224,000 | -34.3% | 28,492 | -29.6% | 0.00% | – |
Q3 2015 | $341,000 | -82.2% | 40,468 | -76.9% | 0.00% | -100.0% |
Q2 2015 | $1,919,000 | -14.9% | 175,199 | +8.7% | 0.00% | 0.0% |
Q1 2015 | $2,254,000 | -39.4% | 161,207 | -26.8% | 0.00% | 0.0% |
Q4 2014 | $3,719,000 | +30.8% | 220,112 | +3.9% | 0.00% | 0.0% |
Q3 2014 | $2,843,000 | +116.5% | 211,868 | +105.4% | 0.00% | 0.0% |
Q2 2014 | $1,313,000 | +286.2% | 103,137 | +260.4% | 0.00% | – |
Q1 2014 | $340,000 | -75.2% | 28,614 | -71.2% | 0.00% | -100.0% |
Q4 2013 | $1,371,000 | +11.5% | 99,212 | +40.6% | 0.00% | 0.0% |
Q3 2013 | $1,230,000 | -49.2% | 70,569 | -52.8% | 0.00% | 0.0% |
Q2 2013 | $2,419,000 | – | 149,416 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 9,766,508 | $19,826,000 | 2.39% |
PLATINUM INVESTMENT MANAGEMENT LTD | 1,286,032 | $2,610,000 | 0.07% |
Clear Harbor Asset Management, LLC | 153,800 | $312,000 | 0.06% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 219,652 | $445,000 | 0.03% |
Rock Springs Capital Management LP | 270,000 | $548,000 | 0.02% |
Alambic Investment Management, L.P. | 77,665 | $158,000 | 0.02% |
Marshall Wace North America L.P. | 1,173,515 | $2,382,000 | 0.01% |
Baker Brothers Advisors | 580,400 | $1,178,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 459,000 | $932,000 | 0.01% |
Intellectus Partners, LLC | 13,000 | $26,000 | 0.01% |